Nicotinic Acid as a Phosphate-lowering Agent in Patients with End-stage Renal Disease on Maintenance Hemodialysis: A Single-center Prospective Study

Background Hyperphosphatemia increases the risk of mortality and morbidity in patients with end-stage renal disease (ESRD). In addition to dietary restriction and renal replacement therapy, phosphorus-binding agents are the mainstay of treatment. While the use of calcium-containing binders has certa...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalid, Syed A, Inayat, Faisal, Tahir, Muhammad K, Younus, Aamna, Ahmad, Hafiz Ijaz, Bokhari, Syed Rizwan A, Yaqoob, Usman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599467/
https://www.ncbi.nlm.nih.gov/pubmed/31281749
http://dx.doi.org/10.7759/cureus.4566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599467/
https://www.ncbi.nlm.nih.gov/pubmed/31281749
http://dx.doi.org/10.7759/cureus.4566

Ejemplares similares